236 related articles for article (PubMed ID: 30346711)
1. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
[TBL] [Abstract][Full Text] [Related]
2. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba
Anwar A; Siddiqui R; Raza Shah M; Khan NA
J Microbiol Biotechnol; 2019 May; 29(5):713-720. PubMed ID: 31030451
[No Abstract] [Full Text] [Related]
4. Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii.
Anwar A; Abdalla SAO; Aslam Z; Shah MR; Siddiqui R; Khan NA
Parasitol Res; 2019 Jul; 118(7):2295-2304. PubMed ID: 31093751
[TBL] [Abstract][Full Text] [Related]
5. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri.
Rajendran K; Anwar A; Khan NA; Siddiqui R
ACS Chem Neurosci; 2017 Dec; 8(12):2626-2630. PubMed ID: 29206032
[TBL] [Abstract][Full Text] [Related]
6. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole.
Anwar A; Siddiqui R; Hussain MA; Ahmed D; Shah MR; Khan NA
Parasitol Res; 2018 Jan; 117(1):265-271. PubMed ID: 29218442
[TBL] [Abstract][Full Text] [Related]
7. Oleic Acid Coated Silver Nanoparticles Showed Better
Rajendran K; Anwar A; Khan NA; Aslam Z; Raza Shah M; Siddiqui R
ACS Chem Neurosci; 2020 Aug; 11(16):2431-2437. PubMed ID: 31347828
[No Abstract] [Full Text] [Related]
8. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
[TBL] [Abstract][Full Text] [Related]
9. Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B.
Anwar A; Siddiqui R; Raza Shah M; Ahmed Khan N
J Microbiol Biotechnol; 2019 Jan; 29(1):171-177. PubMed ID: 30415525
[TBL] [Abstract][Full Text] [Related]
10. Azole and 5-nitroimidazole based nanoformulations are potential antiamoebic drug candidates against brain-eating amoebae.
Akbar N; Hussain K; Khalid M; Siddiqui R; Shah MR; Khan NA
J Appl Microbiol; 2023 Apr; 134(4):. PubMed ID: 37024269
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids.
Anwar A; Masri A; Rao K; Rajendran K; Khan NA; Shah MR; Siddiqui R
Sci Rep; 2019 Feb; 9(1):3122. PubMed ID: 30816269
[TBL] [Abstract][Full Text] [Related]
12. Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine.
Aqeel Y; Siddiqui R; Anwar A; Shah MR; Khan NA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1283-8. PubMed ID: 26666949
[TBL] [Abstract][Full Text] [Related]
13. Synthetic nanoparticle-conjugated bisindoles and hydrazinyl arylthiazole as novel antiamoebic agents against brain-eating amoebae.
Kanwal ; Mungroo MR; Anwar A; Ali F; Khan S; Abdullah MA; Siddiqui R; Khan KM; Khan NA
Exp Parasitol; 2020 Nov; 218():107979. PubMed ID: 32866583
[TBL] [Abstract][Full Text] [Related]
14. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
[TBL] [Abstract][Full Text] [Related]
15. Anti-Balamuthia mandrillaris and anti-Naegleria fowleri effects of drugs conjugated with various nanostructures.
Siddiqui R; Boghossian A; Alqassim SS; Kawish M; Gul J; Jabri T; Shah MR; Khan NA
Arch Microbiol; 2023 Apr; 205(5):170. PubMed ID: 37017767
[TBL] [Abstract][Full Text] [Related]
16. In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.
Baig AM; Iqbal J; Khan NA
Antimicrob Agents Chemother; 2013 Aug; 57(8):3561-7. PubMed ID: 23669391
[TBL] [Abstract][Full Text] [Related]
17. trans-Cinnamic Acid Conjugated Gold Nanoparticles as Potent Therapeutics against Brain-Eating Amoeba Naegleria fowleri.
Rajendran K; Anwar A; Khan NA; Shah MR; Siddiqui R
ACS Chem Neurosci; 2019 Jun; 10(6):2692-2696. PubMed ID: 30970208
[TBL] [Abstract][Full Text] [Related]
18. Antiamoebic activity of plant-based natural products and their conjugated silver nanoparticles against Acanthamoeba castellanii (ATCC 50492).
Anwar A; Ting ELS; Anwar A; Ain NU; Faizi S; Shah MR; Khan NA; Siddiqui R
AMB Express; 2020 Feb; 10(1):24. PubMed ID: 32016777
[TBL] [Abstract][Full Text] [Related]
19. Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii.
Anwar A; Numan A; Siddiqui R; Khalid M; Khan NA
Parasit Vectors; 2019 Jun; 12(1):280. PubMed ID: 31159839
[TBL] [Abstract][Full Text] [Related]
20. Antiamoebic activities of flavonoids against pathogenic free-living amoebae, Naegleria fowleri and Acanthamoeba species.
Lê HG; Võ TC; Kang JM; Nguyễn TH; Hwang BS; Oh YT; Na BK
Parasites Hosts Dis; 2023 Nov; 61(4):449-454. PubMed ID: 38043540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
